Engineered immune cells target aggressive brain cancer in new trial
Disease control
Recruiting now
This study is testing a new type of personalized cell therapy for adults with a hard-to-treat lymphoma that affects the brain and spinal cord. Doctors will collect a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them back into the p…
Phase: PHASE2 • Sponsor: Hyungwoo Cho • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC